CALL FOR PROPOSALS (Proposal Guidelines pdf)
Diabetes Research Center Pilot & Feasibility Awards
Grants of up to $50,000/year
Grant Submission Deadline: Extended to August 19, 2019
Availability & Purpose of Funds
The Washington University Diabetes Research Center anticipates awarding new Pilot & Feasibility Grants starting 12/01/19.
Funding should support the generation of preliminary data leading to the submission of new applications for independent (NIH, JDRF, or ADA) research grants.
Faculty members from any department at Washington University are encouraged to apply.
New in 2018 and continuing for 2019 applications, Translational Imaging Track: The objective of the track is to enhance collaborative research in translational imaging (preclinical and clinical). The research activities at Mallinckrodt Institute of Radiology (MIR) can be found at: http://www.mir.wustl.edu/research.
The following qualify for grant support under the Pilot & Feasibility Program:
- New faculty members involved in diabetes-related research who have not yet obtained independent funding. Applications from these individuals are most likely to be supported by this mechanism.
- Established investigators not involved in diabetes-related research who propose feasibility studies related to diabetes.
- Established investigators involved in diabetes-related research who propose feasibility studies clearly not related to previously supported research.
Applicants must hold a faculty appointment and be independent investigators. Postdoctoral Fellows or their equivalent are not eligible.
There is no specific citizenship requirement.
Previous recipients of Pilot & Feasibility support are eligible, but first priority will be given to those who have not been supported by this program.
Award & Review
Grants of up to $50,000/year (direct costs) for one year are awarded with a second year of funding possible based on research progress.
Investigators pursuing the translational imaging track may request supplemental funds provided by MIR up to $15,000/year for preclinical and up to $20,000/year for preclinical or clinical imaging research utilizing cyclotron-produced radiopharmaceuticals for costs associated with the use of research imaging facilities. Translational imaging resources can be found at: https://www.mir.wustl.edu/research/research-support-facilities. For questions regarding the imaging research facilities, contact Kooresh Shoghi, Ph.D. (preclinical) at email@example.com or Pamela Woodard, M.D. (clinical) at firstname.lastname@example.org.
Applications are evaluated by external reviewers and the Diabetes Research Center Pilot & Feasibility Review Committee.
Grant Submission Deadline – 5 pm on August 19, 2019.
Instructions for preparation and submission are found in the attached Call for Proposals and Application Guidelines.
Anticipated Start Date of Funding – December 1, 2019.
Successful proposals must be approved, if applicable, by the Human Studies, Animal Studies, Biosafety, and Radiation Safety Committees. Regulatory approvals may be “Pending” at the time of application.
Questions: Contact Karen Muehlhauser at: email@example.com